Symptoms of overdose include central nervous system depression, coma, difficulty swallowing, dizziness, drowsiness, head tilted to the side, low blood pressure, muscle twitching, rigid muscles, salivation, tremors, walking disturbances, and weakness.
A thioxanthine used as an antipsychotic agent. Its effects are similar to the phenothiazine antipsychotics.
Fitur visualisasi ini dikembangkan menggunakan pendekatan Graph Theory untuk memetakan hubungan polifarmasi dan molekuler. Entitas (Obat, Target, Gen) direpresentasikan sebagai Simpul (Nodes), sedangkan hubungan biologisnya sebagai Sisi (Edges).
drugbank-id dan name pada skema XML DrugBank.targets/target yang memuat polipeptida sasaran.gene-name dan varian snp-effects.Tata letak grafik menggunakan algoritma Force-Directed Graph (Barnes-Hut). Model fisika ini menerapkan gaya tolak-menolak antar simpul (Gravitasi: -3000) agar tidak tumpang tindih, serta gaya pegas (Spring: 0.04) pada garis penghubung untuk fleksibilitas interaksi.
| Deferasirox | The serum concentration of Thiothixene can be increased when it is combined with Deferasirox. |
| Peginterferon alfa-2b | The serum concentration of Thiothixene can be increased when it is combined with Peginterferon alfa-2b. |
| Leflunomide | The serum concentration of Thiothixene can be decreased when it is combined with Leflunomide. |
| Teriflunomide | The serum concentration of Thiothixene can be decreased when it is combined with Teriflunomide. |
| Buprenorphine | Thiothixene may increase the central nervous system depressant (CNS depressant) activities of Buprenorphine. |
| Doxylamine | Doxylamine may increase the central nervous system depressant (CNS depressant) activities of Thiothixene. |
| Dronabinol | Dronabinol may increase the central nervous system depressant (CNS depressant) activities of Thiothixene. |
| Droperidol | Droperidol may increase the central nervous system depressant (CNS depressant) activities of Thiothixene. |
| Hydrocodone | Thiothixene may increase the central nervous system depressant (CNS depressant) activities of Hydrocodone. |
| Magnesium sulfate | The therapeutic efficacy of Thiothixene can be increased when used in combination with Magnesium sulfate. |
| Methotrimeprazine | Thiothixene may increase the central nervous system depressant (CNS depressant) activities of Methotrimeprazine. |
| Metyrosine | Thiothixene may increase the sedative activities of Metyrosine. |
| Minocycline | Minocycline may increase the central nervous system depressant (CNS depressant) activities of Thiothixene. |
| Mirtazapine | Thiothixene may increase the central nervous system depressant (CNS depressant) activities of Mirtazapine. |
| Nabilone | Nabilone may increase the central nervous system depressant (CNS depressant) activities of Thiothixene. |
| Orphenadrine | Thiothixene may increase the central nervous system depressant (CNS depressant) activities of Orphenadrine. |
| Paraldehyde | Thiothixene may increase the central nervous system depressant (CNS depressant) activities of Paraldehyde. |
| Perampanel | Perampanel may increase the central nervous system depressant (CNS depressant) activities of Thiothixene. |
| Rotigotine | Thiothixene may increase the sedative activities of Rotigotine. |
| Rufinamide | The risk or severity of adverse effects can be increased when Rufinamide is combined with Thiothixene. |
| Sodium oxybate | Thiothixene may increase the central nervous system depressant (CNS depressant) activities of Sodium oxybate. |
| Suvorexant | Thiothixene may increase the central nervous system depressant (CNS depressant) activities of Suvorexant. |
| Tapentadol | Tapentadol may increase the central nervous system depressant (CNS depressant) activities of Thiothixene. |
| Thalidomide | Thiothixene may increase the central nervous system depressant (CNS depressant) activities of Thalidomide. |
| Zolpidem | Thiothixene may increase the central nervous system depressant (CNS depressant) activities of Zolpidem. |
| Amisulpride | Thiothixene may increase the antipsychotic activities of Amisulpride. |
| Methylphenidate | The risk or severity of adverse effects can be increased when Thiothixene is combined with Methylphenidate. |
| Dexmethylphenidate | The risk or severity of adverse effects can be increased when Thiothixene is combined with Dexmethylphenidate. |
| Metoclopramide | The risk or severity of adverse effects can be increased when Metoclopramide is combined with Thiothixene. |
| Quinagolide | The therapeutic efficacy of Quinagolide can be decreased when used in combination with Thiothixene. |
| Sulpiride | Thiothixene may increase the antipsychotic activities of Sulpiride. |
| Methadone | The risk or severity of adverse effects can be increased when Methadone is combined with Thiothixene. |
| Lithium citrate | Lithium citrate may increase the neurotoxic activities of Thiothixene. |
| Lithium hydroxide | Lithium hydroxide may increase the neurotoxic activities of Thiothixene. |
| Mequitazine | Thiothixene may increase the arrhythmogenic activities of Mequitazine. |
| Atomoxetine | The metabolism of Atomoxetine can be decreased when combined with Thiothixene. |
| Dicoumarol | The risk or severity of adverse effects can be increased when Thiothixene is combined with Dicoumarol. |
| Phenindione | The risk or severity of adverse effects can be increased when Thiothixene is combined with Phenindione. |
| Phenprocoumon | The risk or severity of adverse effects can be increased when Thiothixene is combined with Phenprocoumon. |
| 4-hydroxycoumarin | The risk or severity of adverse effects can be increased when Thiothixene is combined with 4-hydroxycoumarin. |
| Coumarin | The risk or severity of adverse effects can be increased when Thiothixene is combined with Coumarin. |
| Ethyl biscoumacetate | The risk or severity of adverse effects can be increased when Thiothixene is combined with Ethyl biscoumacetate. |
| Fluindione | The risk or severity of adverse effects can be increased when Thiothixene is combined with Fluindione. |
| Clorindione | The risk or severity of adverse effects can be increased when Thiothixene is combined with Clorindione. |
| Diphenadione | The risk or severity of adverse effects can be increased when Thiothixene is combined with Diphenadione. |
| Tioclomarol | The risk or severity of adverse effects can be increased when Thiothixene is combined with Tioclomarol. |
| (S)-Warfarin | The risk or severity of adverse effects can be increased when Thiothixene is combined with (S)-Warfarin. |
| Abiraterone | The serum concentration of Thiothixene can be increased when it is combined with Abiraterone. |
| Cyproterone acetate | The metabolism of Thiothixene can be increased when combined with Cyproterone acetate. |
| Ethanol | Thiothixene may increase the central nervous system depressant (CNS depressant) activities of Ethanol. |
| Azelastine | Thiothixene may increase the central nervous system depressant (CNS depressant) activities of Azelastine. |
| Brimonidine | Brimonidine may increase the central nervous system depressant (CNS depressant) activities of Thiothixene. |
| Zimelidine | The risk or severity of adverse effects can be increased when Thiothixene is combined with Zimelidine. |
| Dapoxetine | The risk or severity of adverse effects can be increased when Thiothixene is combined with Dapoxetine. |
| Seproxetine | The risk or severity of adverse effects can be increased when Thiothixene is combined with Seproxetine. |
| Citalopram | The risk or severity of QTc prolongation can be increased when Thiothixene is combined with Citalopram. |
| Duloxetine | The risk or severity of adverse effects can be increased when Thiothixene is combined with Duloxetine. |
| Paroxetine | The risk or severity of adverse effects can be increased when Thiothixene is combined with Paroxetine. |
| Sertraline | The risk or severity of adverse effects can be increased when Thiothixene is combined with Sertraline. |
| Sibutramine | The risk or severity of adverse effects can be increased when Thiothixene is combined with Sibutramine. |
| Nefazodone | The risk or severity of adverse effects can be increased when Thiothixene is combined with Nefazodone. |
| Escitalopram | The risk or severity of adverse effects can be increased when Thiothixene is combined with Escitalopram. |
| Milnacipran | The risk or severity of adverse effects can be increased when Thiothixene is combined with Milnacipran. |
| Desvenlafaxine | The risk or severity of adverse effects can be increased when Thiothixene is combined with Desvenlafaxine. |
| Levomilnacipran | The risk or severity of adverse effects can be increased when Levomilnacipran is combined with Thiothixene. |
| Indalpine | The risk or severity of adverse effects can be increased when Thiothixene is combined with Indalpine. |
| Ritanserin | The risk or severity of adverse effects can be increased when Thiothixene is combined with Ritanserin. |
| Alaproclate | The risk or severity of adverse effects can be increased when Thiothixene is combined with Alaproclate. |
| Carbidopa | The therapeutic efficacy of Carbidopa can be decreased when used in combination with Thiothixene. |
| Metixene | The therapeutic efficacy of Metixene can be decreased when used in combination with Thiothixene. |
| Trihexyphenidyl | The therapeutic efficacy of Trihexyphenidyl can be decreased when used in combination with Thiothixene. |
| Procyclidine | The therapeutic efficacy of Procyclidine can be decreased when used in combination with Thiothixene. |
| Profenamine | The therapeutic efficacy of Profenamine can be decreased when used in combination with Thiothixene. |
| Apomorphine | The therapeutic efficacy of Apomorphine can be decreased when used in combination with Thiothixene. |
| Biperiden | The therapeutic efficacy of Biperiden can be decreased when used in combination with Thiothixene. |
| Amantadine | The therapeutic efficacy of Amantadine can be decreased when used in combination with Thiothixene. |
| Memantine | The therapeutic efficacy of Memantine can be decreased when used in combination with Thiothixene. |
| Pergolide | The therapeutic efficacy of Pergolide can be decreased when used in combination with Thiothixene. |
| 3,5-Dinitrocatechol | The therapeutic efficacy of 3,5-Dinitrocatechol can be decreased when used in combination with Thiothixene. |
| Etilevodopa | The therapeutic efficacy of Etilevodopa can be decreased when used in combination with Thiothixene. |
| Dexetimide | The therapeutic efficacy of Dexetimide can be decreased when used in combination with Thiothixene. |
| Opicapone | The therapeutic efficacy of Opicapone can be decreased when used in combination with Thiothixene. |
| Piribedil | The therapeutic efficacy of Piribedil can be decreased when used in combination with Thiothixene. |
| Benserazide | The therapeutic efficacy of Benserazide can be decreased when used in combination with Thiothixene. |
| Tropatepine | The therapeutic efficacy of Tropatepine can be decreased when used in combination with Thiothixene. |
| Melevodopa | The therapeutic efficacy of Melevodopa can be decreased when used in combination with Thiothixene. |
| Dihydroergocryptine | The therapeutic efficacy of Dihydroergocryptine can be decreased when used in combination with Thiothixene. |
| Phenglutarimide | The therapeutic efficacy of Phenglutarimide can be decreased when used in combination with Thiothixene. |
| Mazaticol | The therapeutic efficacy of Mazaticol can be decreased when used in combination with Thiothixene. |
| Etybenzatropine | The therapeutic efficacy of Etybenzatropine can be decreased when used in combination with Thiothixene. |
| Budipine | The therapeutic efficacy of Budipine can be decreased when used in combination with Thiothixene. |
| Bornaprine | The therapeutic efficacy of Bornaprine can be decreased when used in combination with Thiothixene. |
| Etanautine | The therapeutic efficacy of Etanautine can be decreased when used in combination with Thiothixene. |
| Dexpramipexole | The therapeutic efficacy of Dexpramipexole can be decreased when used in combination with Thiothixene. |
| Cabergoline | The therapeutic efficacy of Cabergoline can be decreased when used in combination with Thiothixene. |
| Bromocriptine | The therapeutic efficacy of Bromocriptine can be decreased when used in combination with Thiothixene. |
| Rasagiline | The therapeutic efficacy of Rasagiline can be decreased when used in combination with Thiothixene. |
| Tolcapone | The therapeutic efficacy of Tolcapone can be decreased when used in combination with Thiothixene. |
| Entacapone | The therapeutic efficacy of Entacapone can be decreased when used in combination with Thiothixene. |
| Levodopa | The therapeutic efficacy of Levodopa can be decreased when used in combination with Thiothixene. |